AIM
ATRC icon

Alambic Investment Management’s AtriCure ATRC Stock Holding History

Alambic Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-8,200
Closed -$220K – 302
2019
Q1 		$220K Buy
+8,200
New +$249K 0.09% 271

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Alambic Investment Management's ATRC Position: Q2 2019 in Review

Alambic Investment Management sold out of AtriCure (ATRC) in Q2 2019, closing a stake of 8,200 shares — an estimated $220K sold.

Alambic Investment Management first reported a position in ATRC in Q1 2019 and held it in 1 quarter. The position peaked at $220K in Q1 2019. 145 funds tracked by Wall St. Rank hold ATRC as of Q2 2019.

  • Alambic Investment Management reported no remaining AtriCure position as of Q2 2019 after selling out during the quarter.
  • Alambic Investment Management sold 8,200 AtriCure shares in Q2 2019, an estimated $220K.
  • Alambic Investment Management first reported a position in AtriCure in Q1 2019 and held it in 1 quarter.
  • Alambic Investment Management's AtriCure position peaked at $220K in Q1 2019.
  • 145 funds tracked by Wall St. Rank held AtriCure as of Q2 2019.

Based on Alambic Investment Management's 13F filing for Q2 2019, filed 13 Aug 2019.